Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Despite initial responsiveness to both chemotherapy and radiotherapy, small cell lung cancer (SCLC) commonly relapses within months. Although neuroendocrine characteristics may be difficult to demonstrate in individual cases, a relevant expression of somatostatin receptors (SSTR) on the cell surface...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Lapa, Constantin, Hänscheid, Heribert, Wild, Vanessa, Pelzer, Theo, Schirbel, Andreas, Werner, Rudolf A., Droll, Sabine, Herrmann, Ken, Buck, Andreas K., Lückerath, Katharina
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2016
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991436/
https://ncbi.nlm.nih.gov/pubmed/26936994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7706
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg